We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.52%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$287B
AUM Growth
+$18.5B
(+6.9%)
Cap. Flow
-$4.92B
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
26.06%
Holding
3,383
New
280
Increased
1,384
Reduced
1,249
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$672M |
| 2 |
Applied Materials
AMAT
|
+$241M |
| 3 |
Kenvue
KVUE
|
+$220M |
| 4 |
Salesforce
CRM
|
+$210M |
| 5 |
PayPal
PYPL
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.25B |
| 2 |
Advanced Micro Devices
AMD
|
+$526M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$443M |
| 4 |
Chubb
CB
|
+$335M |
| 5 |
Microsoft
MSFT
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.88% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Janux Therapeutics
JANX
$967M
| $697K | ﹤0.01% |
58,745
+12,842
| +28% | +$172K |
|
2777
Fiverr
FVRR
$339M
| $697K | ﹤0.01% |
26,799
-3,454
| -11% | -$104K |
|
|
ARIS
2778
DELISTED
Aris Water Solutions
ARIS
| $697K | ﹤0.01% |
67,492
+11,602
| +21% | +$100K |
|
2779
Inogen
INGN
$164M
| $696K | ﹤0.01% |
60,261
-93,456
| -61% | -$1.1M |
|
2780
Mid Penn Bancorp
MPB
$952M
| $692K | ﹤0.01% |
31,345
-7,834
| -20% | -$179K |
|
2781
Citizens & Northern Corp
CZNC
$455M
| $691K | ﹤0.01% |
35,811
| – | – |
|
2782
SoundThinking
SSTI
$103M
| $690K | ﹤0.01% |
31,550
+1,454
| +5% | +$38.1K |
|
|
LOGC
2783
DELISTED
ContextLogic
LOGC
| $688K | ﹤0.01% |
104,624
+51,481
| +97% | +$408K |
|
2784
BioAtla
BCAB
$5.74M
| $688K | ﹤0.01% |
+4,587
| New | +$789K |
|
|
HLVX
2785
DELISTED
HilleVax
HLVX
| $687K | ﹤0.01% |
39,968
+16,066
| +67% | +$249K |
|
2786
Tilly's
TLYS
$128M
| $684K | ﹤0.01% |
97,637
+51,592
| +112% | +$378K |
|
2787
Kodak
KODK
$983M
| $683K | ﹤0.01% |
147,814
-16,655
| -10% | -$70.2K |
|
|
SEI
2788
Solaris Energy Infrastructure
SEI
$3.82B
| $677K | ﹤0.01% |
81,287
+11,095
| +16% | +$89K |
|
2789
Stoke Therapeutics
STOK
$2.11B
| $676K | ﹤0.01% |
63,627
+7,568
| +14% | +$80.5K |
|
2790
Arbutus Biopharma
ABUS
$915M
| $676K | ﹤0.01% |
293,723
+19,266
| +7% | +$50.1K |
|
2791
NewtekOne
NEWT
$391M
| $674K | ﹤0.01% |
+42,831
| New | +$565K |
|
2792
KRONOS Worldwide
KRO
$989M
| $672K | ﹤0.01% |
76,975
-47,540
| -38% | -$419K |
|
2793
Precigen
PGEN
$2.59B
| $670K | ﹤0.01% |
582,484
-101,101
| -15% | -$119K |
|
2794
CALL
Prothena Corp
PRTA
$450M
| $669K | ﹤0.01% |
+9,800
| New | +$632K |
|
|
GRTS
2795
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $666K | ﹤0.01% |
+341,449
| New | +$800K |
|
2796
Annexon
ANNX
$886M
| $662K | ﹤0.01% |
+188,136
| New | +$822K |
|
2797
Ranpak Holdings
PACK
$473M
| $662K | ﹤0.01% |
146,439
+12,610
| +9% | +$50.1K |
|
2798
Zevra Therapeutics
ZVRA
$686M
| $662K | ﹤0.01% |
+129,730
| New | +$699K |
|
2799
Clarus
CLAR
$143M
| $661K | ﹤0.01% |
72,299
-160,521
| -69% | -$1.42M |
|
2800
Northeast Community Bancorp
NECB
$367M
| $659K | ﹤0.01% |
+44,321
| New | +$598K |
|
Similar funds
VFT
Nuveen's Q2 2023 Portfolio in Review
As of Q2 2023, Nuveen held 3,383 positions worth $287B, up 6.9% from $269B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Nuveen's Q2 2023 filing shows 280 new, 1,384 increased, 1,249 reduced and 179 closed positions. Its largest new stake was Kenvue: 8,445,273 shares worth $223M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2023 buy was Kenvue: 8,445,273 shares worth $223M.
- Nuveen added most to Amazon in Q2 2023, an estimated $672M increase.
- Nuveen's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.25B.
- Nuveen fully exited Qualtrics International Inc. Class A Common Stock in Q2 2023, selling an estimated $130M.
- Nuveen's ten largest holdings make up 26% of its $287B portfolio in Q2 2023.
- Nuveen opened 280 new positions and closed 179 in Q2 2023.
- Nuveen's portfolio value rose 6.9% quarter-over-quarter to $287B.
Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.